StockData
Palvella Therapeutics, Inc. logo

Palvella Therapeutics, Inc. (PVLA) stock

PVLANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$146.58+2.23 (+1.54%)

Close on Nov 18, 2026Market cap $2.11BP/E –Yield –

Palvella Therapeutics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Palvella Therapeutics's EV/EBITDA was 0.6× on Nov 29, 2024.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2024Nov 29, 20240.6×–

More Palvella Therapeutics figures

See a number that looks wrong?